Sabeluzole stabilizes the neuronal cytoskeleton

Neurobiology of Aging

Volumn 17, Issue 4, 1996, Pages 573-581

  Geerts, Hugo ^a   Nuydens, Rony ^a   De Jong, Miriam ^a   Cornelissen, Frans ^a   Nuyens, Roger ^a   Wouters, Luc ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Alzheimer's disease; Cytoskeletal stability; Neurotoxicity; Sabeluzole; Tau phosphorylation

Indexed keywords

SABELUZOLE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CYTOSKELETON; DRUG MECHANISM; MOUSE; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0029839036     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-4580(96)00067-X     Document Type: Article

References (16)

1. del Alonso, A.; Zaidi, T.; Grundke-Iqbal, I.; Iqbal, K. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 91:5562-5566; 1994.
2. Arriagada, P.; Marzloff, K.; Hyman, B. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 42:1681-1688; 1992.
3. Baas, P.; Pienkowksi, T.; Kosik, K. Processes induced by tau expression in Sf9 cells have an axon-like microtubule organization. J. Cell Biol. 115:1333-1344; 1991.
4. Bernheimer, H.; Birkmayer, W.; Hornykiewicz, O.; Jellinger, K.; Seitelberger, F. Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological and neurochemical correlations. J. Neurol. Sci. 20:415-455; 1973.
5. Biernat, J.; Gustke, N.; Drewes, G.; Mandelkow, E. G.; Mandelkow, E. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11:153-163; 1993.
6. Boffa, L.; Mariani, M.; Parker, I. Selective hypermethylation of transcribed nucleosomal DNA by sodium butyrate. Exp. Cell Res. 211:420-423; 1994.
7. Bottenstein, J. E.; Sato, G. H. Growth of rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci USA 76(1):514-517; 1979.
8. Bramblett, G.; Goedert, M.; Jakes, R.; Merrick, S.; Trojanowski, J.; Lee, V. Abnormal tau phophorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10:1089-1099; 1993.
9. Brandt, R.; Lee, G. Orientation, assembly and stability of microtubule bundles induced by a fragment of tau protein. Cell Motil. Cytoskel. 28:143-154; 1994.
10. Burke, W.; Raghu, G.; Strong, R. Taxol protects against calcium-mediated death of differentiated rat pheochromocytoma cells. Life Sci. 55(16):PL313-319; 1994.
11. Calne, D.; Zigmond, M. Compensatory mechanisms in degenerative neurologic disease. Insigths from Parkinsonsism. Arch. Neurol. 48:361-364; 1991.
12. Clincke, G.; Tritsmans, L. Sabeluzole increases consistent retrieval during serial learning and relearning of nonsense syllables. Psychopharmacology (Berlin) 96:309-310; 1988.
13. Cornelissen, F.; Nuyens, R.; Nuydens, R.; Geerts, H. An automatic image analysis system for quantifying morphology in neuronal cell cultures. Neuroimaging (submitted).
14. De Brabander, M.; Van de Veire, R.; Aerts, F.; Borgers, M.; Janssen, P. The effect of methyl[5-(2)thienylcarbonyl)-1H-benzimidazol-2-yl]carbamate, (R17934, NSC 238159), a new synthetic antitumoral drug interfering with microtubules, on mammalian cells cultured in vitro. Cancer Res. 36:905-916; 1976.
15. Drechsel, D.; Hyman, A.; Cobb, M.; Kirschner, M. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol. Biol. Cell. 3:1141-1154; 1992.
16. Drewes, G.; Lichtenberger, B.; Doring, F.; Mandelkow, E. M.; Biernat, J.; Goris, J.; Doree, M.; Mandelkow, E. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J. 11:2131-2138; 1992.